Dr. Melnick is Chief of the Department of Pathology and Clinical Laboratories at Miami Children’s Hospital. He joined the Department of Pathology in 1992 following his Residency training at Mount Sinai Medical Center in Miami Beach. He earned his B.Sc. in Physics and Ph.D. in Chemistry at McGill University, Montréal, Québec and his Medical Degree at Queen’s University, Kingston, Ontario. He is a Diplomat of the American Board of Pathology in Anatomic and Clinical Pathology and Fellow of the College of American Pathologists. Dr. Melnick’s academic interests in the field of medicinal discovery stem from research conducted at McGill University that was instrumental in establishing a research laboratory dedicated to ethnobotanical research at Miami Children’s Hospital in 1999. The laboratory under his direction accumulated intellectual property including; RR1 a patented (US 7,425,548 B2) immune-modulating ?-D-glucan polysaccharide isolated from Tinospora cordifolia, a highly regarded medicinal botanical commonly used for its immune stimulating properties in Ayurvedic medicine and Amooranin, a natural pentacyclic triterpenoid drug isolated from the stem bark of Amoora rohituka, a tropical medicinal tree indigenous to the Indian subcontinent.